A Novel Mutation in the Arginine Vasopressin Receptor 2 Gene Causing Congenital Nephrogenic Diabetes Insipidus
Author(s) -
Aslı Çelebi Tayfur,
Tuğçe Karaduman,
Merve Özcan Türkmen,
Dilara Şahin,
Aysun Çaltık Yılmaz,
Bahar Büyükkaragöz,
Ayşe Derya Buluş,
Hatice Mergen
Publication year - 2018
Publication title -
journal of clinical research in pediatric endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.566
H-Index - 35
eISSN - 1308-5735
pISSN - 1308-5727
DOI - 10.4274/jcrpe.0097
Subject(s) - nephrogenic diabetes insipidus , missense mutation , proband , endocrinology , medicine , arginine vasopressin receptor 2 , vasopressin , diabetes insipidus , polyuria , exon , mutation , genetics , biology , gene , diabetes mellitus , receptor , antagonist
Congenital nephrogenic diabetes insipidus (CNDI) is a rare inherited disorder characterized by a renal insensitivity to arginine vasopressin (AVP). In the majority of the cases, CNDI is caused by mutations in the arginine vasopressin receptor 2 ( AVPR2 ) gene. Our objective is to report a novel mutation in the AVPR2 gene causing CNDI in a 6-year-old boy, presenting with growth failure and dull normal cognitive functions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom